RESUMEN
Non-encapsulated or non-typable Haemophilus influenzae (NTHi) is a major cause of middle ear infections in young children. HtrA has been identified as a vaccine candidate antigen from NTHi; therefore physicochemical characterization of this antigen is important for vaccine development. Recombinant NTHi HtrA has been expressed in E. coli and shown to have serine protease activity. Several mutant, recombinant HtrA proteins were expressed and purified to obtain suitable vaccine antigens lacking protease activity. Two mutants with alterations at the putative active site His91 and Ser197, designated H91A and S197A were examined by circular dichroic spectropolarimetry (CD) to evaluate secondary structure. The S197A mutant had a more random secondary structure compared to wild-type rHtrA or H91A. It is likely that improper folding of S197A accounts for its lack of immunoprotective properties in a chinchilla model of otitis media.
Asunto(s)
Antígenos Bacterianos/química , Vacunas contra Haemophilus/inmunología , Otitis Media/prevención & control , Vacunas Sintéticas/inmunología , Animales , Antígenos Bacterianos/genética , Antígenos Bacterianos/inmunología , Chinchilla/inmunología , Dicroismo Circular , Escherichia coli/metabolismo , Vacunas contra Haemophilus/genética , Mutación , Otitis Media/inmunología , Estructura Secundaria de Proteína , Conejos , Vacunas Sintéticas/genéticaRESUMEN
The temporal expression of protein and mRNA encoding the collagen-binding heat-shock glycoprotein, gp46, were determined in the heart, kidney, and lung during early rat postnatal development. The steady-state levels of collagen types I and IV mRNA expression were also examined to determine if gp46 and these collagen types are co-regulated during ontogenesis. Western blot analysis using a monoclonal antibody to gp46 revealed that gp46 levels are developmentally regulated. In heart and kidney, gp46 levels were high on days 3 and 8, reduced significantly on day 25, and low to undetectable on day 69. Protein levels of gp46 in the lung exhibited a similar temporal pattern except on day 3, when very low levels of gp46 were detected. mRNA expression of gp46 during early postnatal development did not correlate with gp46 protein accumulation in these tissues, suggesting a complex pre- and post-translational regulatory scheme. In the heart, protein levels of gp46 correlated well with collagen type I alpha 1(I) mRNA expression but not with collagen type IV alpha 1(IV). In contrast, gp46 protein levels closely paralleled alpha 1(IV) expression in the kidney. Gp46 levels exhibited no apparent correlation with either alpha 1(I) or alpha 1(IV) levels in the lung. These results show that gp46 is developmentally regulated at both the protein and mRNA levels in a tissue specific manner. The relationship between gp46 and collagen alpha 1(I) and alpha 1(IV) chain mRNA expression also has been shown to be tissue specific.
Asunto(s)
Proteínas Portadoras/biosíntesis , Colágeno/biosíntesis , Regulación del Desarrollo de la Expresión Génica , Corazón/crecimiento & desarrollo , Riñón/metabolismo , Pulmón/metabolismo , Miocardio/metabolismo , Animales , Proteínas Portadoras/genética , Colágeno/genética , Femenino , Glicoproteínas , Riñón/crecimiento & desarrollo , Pulmón/crecimiento & desarrollo , Masculino , Embarazo , ARN Mensajero/biosíntesis , Ratas , Ratas WistarRESUMEN
Several cDNA clones encoding a 46-kDa collagen-binding glycoprotein (gp46) from rat skeletal myoblasts were isolated and sequenced. The cDNA encoded a 17-amino acid signal peptide and a 400-amino acid mature protein, containing three potential N-linked oligosaccharide attachment sites. The cDNA sequence of gp46 shows 93% identity in the coding region with J6, a retinoic acid-inducible gene coding for a protein of unknown function described from embryonal carcinoma F9 cells. The first 41 NH2-terminal amino acids of the predicted J6 sequence are, however, different from the gp46 sequence as a result of a 7-base pair insertion in the gp46 cDNA. In addition, the NH2-terminal amino acid sequence of hsp47, a collagen-binding protein found in chick embryo fibroblasts, shows 64% identity to gp46 over 36 residues. Interestingly, this alignment begins 10 residues inward from the first amino acid in the mature form of gp46. A significant sequence similarity was observed between gp46 and members of the serine protease inhibitor (serpin) family. Unlike other serpins, however, gp46 is both a heat shock and a collagen-binding protein and is localized to the lumen of the endoplasmic reticulum, as suggested by the presence of the RDEL sequence at the COOH terminus. This sequence is similar to other proposed endoplasmic reticulum retention signals.
Asunto(s)
Colágeno/metabolismo , Retículo Endoplásmico/metabolismo , Músculos/metabolismo , Receptores de Superficie Celular/metabolismo , Inhibidores de Serina Proteinasa , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Células Cultivadas , ADN , Datos de Secuencia Molecular , Músculos/citología , Ratas , Receptores de Superficie Celular/genética , Receptores de Colágeno , Mapeo Restrictivo , Alineación de Secuencia , Teratoma , Células Tumorales CultivadasRESUMEN
A major collagen-binding glycoprotein from rat L6 skeletal myoblasts, designated gp46, is phosphorylated in vivo. In this report the relative phosphorylation state of gp46 was examined using isoelectric focusing to identify the phosphorylated and unphosphorylated forms of gp46. Two major and one minor isoform of gp46 were identified that could be related to the phosphorylation state of gp46. The relative percentage of unphosphorylated to phosphorylated gp46 increased 10% in myoblasts heat-shocked at 42 degrees C for 24 h. Treatment of myoblasts with phorbol ester or dibutyryl-cAMP had no effect on the phosphorylation ratio of gp46. Transformation of L6 myoblasts with Rous sarcoma virus, likewise, had no effect on the phosphorylation ratio. However, ras-transformed L6 myoblasts showed a 12% increase in phosphorylation of gp46. These results indicate that gp46 does not undergo large changes in phosphorylation status. Pulse-chase labelling showed that the phosphorylation of gp46 occurred either co-translationally or soon after translation, suggesting that gp46 was phosphorylated by a constitutively active protein kinase.
Asunto(s)
Proteínas de Choque Térmico/química , Glicoproteínas de Membrana/química , Músculos/química , Receptores de Superficie Celular/química , Animales , Western Blotting , Línea Celular , Proteínas de Choque Térmico/aislamiento & purificación , Focalización Isoeléctrica , Glicoproteínas de Membrana/aislamiento & purificación , Músculos/citología , Fosforilación , Ratas , Receptores de Superficie Celular/aislamiento & purificación , Receptores de ColágenoRESUMEN
A major collagen-binding heat-shock glycoprotein from L6 myoblasts, designated gp46, was purified by gelatin-agarose chromatography and ion-exchange chromatography. Purified gp46 was functionally active, as shown by its ability to rebind to gelatin-agarose, and was homogeneous as determined by SDS/polyacrylamide-gel electrophoresis. This is the first reported purification of myoblast gp46 in an active state. Triton X-100-soluble gp46 was found to bind preferentially to immobilized pepsin-treated type IV collagen compared with native type I collagen. gp46, reconstituted into phospholipid vesicles, retained collagen-binding activity. This activity could be destroyed by chemical modification with chloramine-T, but was decreased by only 20-30% following treatment with iodoacetamide or N-ethylmaleimide. Since gp46 is a heat-shock protein, we examined the possibility that it may confer protection on type I collagen from thermal denaturation at temperatures above its normal melting temperature of 41 degrees C. In the presence of gp46 liposomes the apparent melting temperature of type I collagen was marginally increased to 42 degrees C. This change was considered to be too small to be of physiological significance. We have therefore concluded that the role of gp46 in collagen metabolism is unlikely to be related to any thermal-stabilizing function.
Asunto(s)
Proteínas Portadoras/aislamiento & purificación , Colágeno/metabolismo , Glicoproteínas/aislamiento & purificación , Proteínas de Choque Térmico/aislamiento & purificación , Músculos/metabolismo , Animales , Línea Celular , Cromatografía en Gel , Cromatografía por Intercambio Iónico , Electroforesis en Gel de Poliacrilamida , Calor , Liposomas , RatasRESUMEN
A 46-kDa glycoprotein, gp46, which binds collagen has been purified to homogeneity from L6 rat skeletal myoblasts. The procedure involves extraction of crude myoblast membranes with 1% sodium dodecyl sulfate followed by concanavalin A affinity chromatography and preparative gel electrophoresis. The sequence of 15 N-terminal amino acids had some resemblance to a sequence in myosin light chains. The oligosaccharide chains of the glycoprotein can be released by treatment with endoglycosidase H, suggesting that gp46 has high-mannose type of glycans. Galactose and sialic acid are not detected in the purified protein. gp46 is widely distributed and conserved in different cell lines as determined by immunoblotting using a monoclonal anti-gp46 antibody. High levels of gp46 were found in several fibroblastic and myogenic cell lines, but not in a hematopoietic cell line. Undifferentiated F9 embryonal carcinoma cells lacked gp46 but the glycoprotein was induced when the cells were made to differentiate in the presence of retinoic acid. Broad survey of gp46 in different cell lines also suggests that it is present mainly in those cell lines which attach to the substratum and produce collagens. Although the function of gp46 is not yet known, the evidence suggests that it is developmentally regulated and is probably involved in the synthesis or assembly of collagen in the endoplasmic reticulum.
Asunto(s)
Glicoproteínas/aislamiento & purificación , Músculos/análisis , Receptores de Superficie Celular/aislamiento & purificación , Aminoácidos/análisis , Animales , Diferenciación Celular , Concanavalina A/metabolismo , Humanos , Ratones , Especificidad de Órganos , Receptores de Colágeno , Solubilidad , Células Tumorales CultivadasRESUMEN
Previous work using glycosylation inhibitors has suggested that high-mannose type but not complex type oligosaccharides on the surface of cells may play a role in the differentiation of skeletal myoblasts. Earlier, we had shown that a concanavalin A-resistant mutant derived from an L6 myoblast line fails to differentiate in a medium containing 10% horse serum. Here we show that one such concanavalin A-resistant mutant (D-1) which was reported to have oligosaccharides of the type Man(3-5)G1cNAc2, shows significant fusion ability when grown in media containing 1% horse serum. Lowering the serum concentration did not alter the dolichol-phosphate mannosyltransferase activity in D-1 which remained at low levels compared to L6. The incorporation of [3H]mannose in D-1 was found to be 60% of L6 in 10% serum whereas in 1% serum the incorporation into D-1 was further reduced to 30% of L6. [3H]mannose-labeled ConA-binding proteins isolated from L6 were quantitatively and qualitatively similar in cells grown in either 10 or 1% serum. However, in D-1 cells a further decrease in the ConA-binding ability of these glycoproteins was observed. Biochemical differentiation also occurs in D-1 upon fusion in 1% serum as seen by the increase in mRNA levels of the muscle-specific markers myosin light chain and troponin T. These results suggest the high-mannose type of oligosaccharides may not be involved in myoblast differentiation.
Asunto(s)
Glicoproteínas/metabolismo , Músculos/citología , Polisacáridos/metabolismo , Animales , Sangre , Diferenciación Celular , Fusión Celular , Línea Celular , Concanavalina A/metabolismo , Concanavalina A/farmacología , Medios de Cultivo , Glicopéptidos/metabolismo , Manosa/metabolismo , Manosiltransferasas/metabolismo , Músculos/metabolismo , Mutación , Miosinas/genética , ARN Mensajero/análisis , Receptores de Concanavalina A/metabolismo , Troponina/genéticaRESUMEN
We had earlier demonstrated that a 46-kDa glycoprotein is involved in the differentiation of rat skeletal myoblasts. We now show that the binding of this glycoprotein to collagen and gelatin is disrupted by Arg-Gly-Asp (RGD) containing peptide but not by Arg-Gly-Glu (RGE). The former peptide also selectively elutes the 46-kDa glycoprotein bound to gelatin-Sepharose. Since all other proteins which bind RGD sequences have been found at the cell surface, we attempted to localize the 46-kDa glycoprotein by means of immuno fluorescent staining and radioiodine labeling. Surprisingly, the majority of the protein was found to be localized in the endoplasmic reticulum. Protease treatment of a microsomal fraction revealed that the protein is in the interior of the reticulum. Immunoprecipitation experiments, using a polyclonal antibody against the 46-kDa protein, demonstrated that no closely related proteins exist in myoblasts and also confirmed that the protein was not a fragment of a cell-surface localized protein. These findings suggest that the RGD sequence is also used in protein recognition within the cell.
Asunto(s)
Músculos/citología , Oligopéptidos/metabolismo , Receptores de Superficie Celular/metabolismo , Secuencia de Aminoácidos , Animales , Diferenciación Celular , Peso Molecular , Ratas , Receptores de Colágeno , Relación Estructura-Actividad , Especificidad por SustratoRESUMEN
We have previously described a myoblast cell surface glycoprotein of the molecular mass 46,000 (gp46), which is associated with myoblast differentiation. In this report we demonstrate that gp46 binds specifically to gelatin-Sepharose and in this respect is similar to a glycoprotein of the molecular mass 47,000, which has earlier been described as a cell surface localized protein in mouse parietal endoderm cells and in chick embryo fibroblasts. To ascertain the relationship of gp46 to myoblast differentiation, wild-type L6 myoblasts, as well as two concanavalin A (ConA) resistant, differentiation-negative, myoblast mutants (D-1 and C-8), were examined for gp46 expression. In the mutant designated D-1, which has a defect in dolichol mannosyl transferase, both mannose incorporation into gp46 and ConA binding to gp46 was reduced compared with L6, without markedly affecting the gelatin adhesion properties of gp46. Western blotting with a monoclonal antibody against gp46 was used to show that the expression of gp46 was normal in D-1 but was reduced in mutant C-8 compared with L6. Reduction occurred both in the plasma membrane and endoplasmic reticulum fractions of C-8 compared with wild-type L6. In L6 myoblasts, the expression of gp46 remained constant during myoblast replication and fusion but decreased markedly postfusion. In the nonfusing myoblast mutants D-1 and C-8 and in wild-type L6 cells that were prevented from fusing by treatment with 5-bromo-2'-deoxyuridine, the expression of gp46 remained invariant. We suggest that collagen interactions, mediated by gp46, are important for normal rat skeletal muscle differentiation.
Asunto(s)
Gelatina/metabolismo , Glicoproteínas de Membrana/metabolismo , Músculos/citología , Animales , Anticuerpos Monoclonales/aislamiento & purificación , Adhesión Celular , Diferenciación Celular , Línea Celular , Concanavalina A/metabolismo , Glicosilación , Glicoproteínas de Membrana/análisis , Glicoproteínas de Membrana/inmunología , Glicoproteínas de Membrana/aislamiento & purificación , Ratones , Músculos/metabolismo , Mutación , Mapeo Peptídico , Unión Proteica , RatasRESUMEN
A gelatin-binding glycoprotein from L6 rat myoblasts, designated gp46, was shown to be phosphorylated in vivo. This phosphorylation was increased slightly (18%) by phorbol ester treatment of L6 suggesting protein kinase C involvement. Purified gp46 could be phosphorylated in vitro with protein kinase C, but not by the catalytic subunit of cAMP-dependent protein kinase. Comparison of the phosphotryptic peptide maps of in vitro and in vivo labeled gp46 suggested that in vivo phosphorylation of gp46 may be mediated by protein kinase C.
Asunto(s)
Proteínas Portadoras/metabolismo , Músculos/metabolismo , Proteína Quinasa C/metabolismo , Animales , Línea Celular , Gelatina/metabolismo , Cinética , Fragmentos de Péptidos/aislamiento & purificación , Fosfatos/metabolismo , Fosforilación , Ratas , Tripsina/metabolismoRESUMEN
Rat skeletal myoblasts contain two cytosolic cAMP-dependent protein kinases, types I and II. Photoaffinity labeling with 8-azido-cAMP reveals the presence of regulatory subunits of Mr = 52,000, 47,000, and 36,000. The Mr = 52,000 and 47,000 subunits are very likely RII and RI, respectively, while the Mr = 36,000 subunit appears to be a proteolytic product of RI, as judged by its cross-reactivity to anti-RI antiserum. The total protein kinase activity increases about 3-fold during the fusion of myoblasts. In parallel with this increase, the concentration of RI subunit also increases, while the levels of RII remain unchanged. Myoblast mutants which lack the capability to differentiate both biochemically and morphologically also lack the ability to increase the concentration of RI subunit. This ability is restored in complementing somatic hybrids which regain the capability to differentiate.
Asunto(s)
Desarrollo de Músculos , Proteínas Quinasas/metabolismo , Marcadores de Afinidad/metabolismo , Animales , Azidas/metabolismo , Diferenciación Celular , Línea Celular , Cromatografía DEAE-Celulosa , AMP Cíclico/análogos & derivados , AMP Cíclico/metabolismo , Fotoquímica , Protamina Quinasa/metabolismo , RatasRESUMEN
From a highly myogenic permanent line of rat skel-myoblasts (L6), we have isolated two classes of single step concanavalin A-resistant mutants. The RI class is about 2-fold and RII about 5-fold more resistant than the parental cells to the lethal action of concanavalin A. In all of the mutants, both the morphological differentiation (i.e. fusion to form myotubes) and biochemical differentiation, measured by the appearance of creatine kinase and acetylcholine receptors, are absent. The biochemical lesion in the RI type of mutants is not known, but RII type of mutants is unable to catalyze transfer of mannose from GDP-mannose into a lipid-linked form. Concanavalin A binding to separated membrane proteins from RII type of mutants on polyacrylamide gels is reduced 80% compared to wild type cells. In the RI type of mutants, however, only one major band, approximately 46,000 daltons, does not bind concanavalin A to the same extent as the wild type cells. In somatic cell hybridizations, RI type of mutants complements the RII type. In the hybrids, fusion as well as creatine kinase and acetylcholine receptors reappear, although not to the same extent as in the wild type cells. The 46,000-dalton band also reappears in the complementing hybrids. Thus, this protein may play some crucial role in myogenesis.
Asunto(s)
Glicoproteínas/fisiología , Proteínas de la Membrana/fisiología , Músculos/fisiología , Receptores de Concanavalina A/metabolismo , Animales , Diferenciación Celular , Línea Celular , Membrana Celular/fisiología , Membrana Celular/ultraestructura , Supervivencia Celular/efectos de los fármacos , Células Clonales , Concanavalina A/farmacología , Creatina Quinasa/metabolismo , Resistencia a Medicamentos , Células Híbridas/metabolismo , Mutación , Ratas , Receptores Colinérgicos/metabolismoRESUMEN
The differentiation of a permanent line of rat skeletal myoblasts is inhibited by a low concentration of tunicamycin in the growth medium. At a level of 0.9 micrograms/mL, mannose incorporation in trichloroacetic-acid-insoluble material is inhibited to the extent of about 50% by the antibiotic. Blotting of glycoproteins of the cytoplasmic membrane of myoblasts separated by gel electrophoresis by radioiodinated concanavalin A revealed that four major glycoproteins of 230,0000, 145,000, 119,000, and 46,000 daltons were present in lower relative amounts in the plasma membrane following tunicamycin treatment. The 119,000 dalton glycoprotein was a major radioiodinated protein in intact cells and was presumably localized on the periphery of the membrane. The effect of tunicamycin on both fusion and glycosylation of membrane proteins could be reversed by N-acetylglucosamine, but not by the protease inhibitors leupeptin and pepstatin.
Asunto(s)
Acetilglucosamina/farmacología , Glucosamina/análogos & derivados , Músculos/fisiología , Tunicamicina/farmacología , Animales , División Celular/efectos de los fármacos , Fusión Celular/efectos de los fármacos , Línea Celular , Membrana Celular/fisiología , Membrana Celular/ultraestructura , Glicoproteínas/aislamiento & purificación , Cinética , Leupeptinas/farmacología , Proteínas de la Membrana/aislamiento & purificación , Peso Molecular , Músculos/efectos de los fármacos , RatasRESUMEN
Plasma membranes were prepared from primary cell cultures of normal and genetically dystrophic chick embryonic pectoral muscle. These membranes were analyzed both by one-dimensional sodium dodecyl sulphate-polyacrylamide slab gel electrophoresis and by two-dimensional electrophoresis using isoelectric focusing in the first dimension. No marked and reproducible abnormalities could be detected in the synthesis, or accumulation, of plasma membrane proteins of dystrophic muscle cells maintained in culture for periods of up to 6 days. Analysis of the relative rates of protein turnover, analysis of fucose incorporation into plasma membrane proteins, and comparison of iodinated cell surface proteins also failed to reveal distinct abnormalities in plasma membranes derived from cultured dystrophic muscle cells. Although the results obtained do not rule out an early defect in plasma membrane protein biosynthesis during the development of dystrophic skeletal muscle in vivo, they do demonstrate that the synthesis and assembly of at least the major plasma membrane proteins occur normally during the initial phases of terminal differentiation of isolated dystrophic skeletal muscle cells in tissue culture.
Asunto(s)
Proteínas de la Membrana/biosíntesis , Músculos/metabolismo , Distrofia Muscular Animal/metabolismo , Animales , Membrana Celular/metabolismo , Células Cultivadas , Embrión de Pollo , Electroforesis en Gel de Poliacrilamida , Fucosa/metabolismo , Cinética , Leucina/metabolismo , Peso Molecular , Músculos/embriologíaRESUMEN
1. Two distinct classes of protein were detected at the surface of chick-embryo skeletal-muscle cells after iodination of the cells in monolayer culture. 2. The two classes of iodinated proteins differed in their ability to co-purify with a vesicular plasma-membrane fraction prepared from surface-labelled cells. 3. One class consisted of predominantly high-molecular-weight glycoproteins that co-purified with the plasma-membrane fraction, but showed no significant qualitative or quantitative alterations in labelling with 125I and lactoperoxidase during myogenesis. 4. A second class of predominantly lower-molecular-weight proteins showed reproducible quantitative alterations in 125I-labelling during myogenesis but failed to co-purify with the plasma-membrane fraction. 5. This second class of proteins may represent matrix proteins involved in intercellular adhesion or adhesion of cells to the substratum. They are unlikely to be directly required for the process of plasma-membrane fusion during myogenesis, since they do not copurify with a vesicular plasma-membrane fraction known to be capable of Ca2+-dependent fusion in vitro.
Asunto(s)
Proteínas Musculares/metabolismo , Animales , Fusión Celular/efectos de los fármacos , Membrana Celular/metabolismo , Células Cultivadas , Embrión de Pollo , Electroforesis en Gel de Poliacrilamida , Glucosamina/metabolismo , Radioisótopos de Yodo , Lactoperoxidasa , Proteínas de la Membrana/aislamiento & purificación , Proteínas de la Membrana/metabolismo , Proteínas Musculares/aislamiento & purificación , Músculos/citología , Músculos/embriologíaRESUMEN
1. Surface labelling of plasma-membrane proteins with 125I, catalysed by lactoperoxidase, and radioactive l-fucose incorporation into glycoprotein were used as plasma-membrane markers for skeletal-muscle cells in culture. 2. Plasma membranes were prepared at various stages of myogenesis in vitro and rates of synthesis and accumulation of proteins in the membranes were compared. 3. Increased synthesis and accumulation of a protein of apparent mol.wt. 70000 occurred in the plasma-membrane fraction concomitant with the onset of myoblast fusion. 4. In cultures in which fusion of myoblasts was inhibited by 5'-bromo-2-deoxyuridine, synthesis and accumulation of the protein of apparent mol.wt. 70000 was selectively inhibited. 5. It is suggested the protein of apparent mol.wt. 70000 may be involved in the process of myoblast fusion.